Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 28 citing articles:

Tumour-infiltrating lymphocytes: from prognosis to treatment selection
Koen Brummel, Anneke L. Eerkens, Marco de Bruyn, et al.
British Journal of Cancer (2022) Vol. 128, Iss. 3, pp. 451-458
Open Access | Times Cited: 131
Prognostic value of CD163+ macrophages in solid tumor malignancies: A scoping review
Henriette Mathiesen, Kristian Juul‐Madsen, Trine Tramm, et al.
Immunology Letters (2025), pp. 106970-106970
Open Access | Times Cited: 1
Regulation of the tumor suppressor PTEN in triple-negative breast cancer
Chengsen Chai, Hong Wu, Yasser Abuetabh, et al.
Cancer Letters (2021) Vol. 527, pp. 41-48
Closed Access | Times Cited: 44
Immune response and inflammation in cancer health disparities
Maeve Kiely, Brittany D. Jenkins, Stefan Ambs
Trends in cancer (2021) Vol. 8, Iss. 4, pp. 316-327
Open Access | Times Cited: 42
Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody
Jessica D. Weaver, Edward C. Stack, Joshua Buggé, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 24
The prognostic values of FOXP3+ tumor-infiltrating T cells in breast cancer: a systematic review and meta-analysis
Yalan Sun, Ying Wang, Fang Lü, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 6, pp. 1830-1843
Closed Access | Times Cited: 13
Therapeutic Targeting of Tumor-Infiltrating Regulatory T Cells in Breast Cancer
Stéphane Fattori, Hugo Roux, Emilie Connen, et al.
Cancer Research (2022) Vol. 82, Iss. 21, pp. 3868-3879
Closed Access | Times Cited: 19
Targeting acid ceramidase enhances antitumor immune response in colorectal cancer
Yadu Vijayan, Shirley James, Viswanathan Arun, et al.
Journal of Advanced Research (2023) Vol. 65, pp. 73-87
Open Access | Times Cited: 12
Neoadjuvant immune checkpoint blockade triggers persistent and systemic T reg activation which blunts therapeutic efficacy against metastatic spread of breast tumors
Olga Blomberg, Kevin Kos, Lorenzo Spagnuolo, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 11
The prognostic value of the tumor-stroma ratio compared to tumor-infiltrating lymphocytes in triple-negative breast cancer: a review
Layla Andour, Sophie C. Hagenaars, Barbara Gregus, et al.
Virchows Archiv (2025)
Open Access
Current Status of Immune Checkpoint Inhibitors and Treatment Responsive Biomarkers for Triple‐Negative Breast Cancer
Xinran Wang, Lingxia Wang, Yueping Liu
Thoracic Cancer (2025) Vol. 16, Iss. 9
Open Access
Integrative analysis identifies activated anti-tumor immune microenvironment in lung metastasis of pancreatic cancer
Toshihide Sasaki, Satoshi Nishiwada, Kenji Nakagawa, et al.
International Journal of Clinical Oncology (2022) Vol. 27, Iss. 5, pp. 948-957
Closed Access | Times Cited: 13
The breast cancer tumor microenvironment and precision medicine: immunogenicity and conditions favoring response to immunotherapy
Andrea Nicolini, Paola Ferrari, Roberto Silvestri, et al.
Journal of the National Cancer Center (2024) Vol. 4, Iss. 1, pp. 14-24
Open Access | Times Cited: 2
The relationship between high ratios of CD4/FOXP3 and CD8/CD163 and the improved survivability of metastatic triple-negative breast cancer patients: a multicenter cohort study
Jeffry Beta Tenggara, Andhika Rachman, Joedo Prihartono, et al.
BMC Research Notes (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Spatial Distribution and Densities of CD103+ and FoxP3+ Tumor Infiltrating Lymphocytes by Digital Analysis for Outcome Prediction in Breast Cancer
Ronald Chan, Chaiwat Aphivatanasiri, Ivan K. Poon, et al.
The Oncologist (2023) Vol. 29, Iss. 3, pp. e299-e308
Open Access | Times Cited: 5
The prognostic impact of tumor-infiltrating B lymphocytes in patients with solid malignancies: A systematic review and meta-analysis
Hao Liu, Zhuoqun Li, Xuan Han, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 181, pp. 103893-103893
Closed Access | Times Cited: 8
Prognostic value and distribution pattern of tumor infiltrating lymphocytes and their subsets in distant metastases of advanced breast cancer
Xinyi Sun, Cheng-Qin Wang, Yan Mao, et al.
Clinical Breast Cancer (2023) Vol. 24, Iss. 3, pp. e167-e176
Open Access | Times Cited: 4
Utility of neutrophil-to-lymphocyte ratio as an indicator of tumor immune status in non-small cell lung cancer
Kazuma Iwata, Ken Suzawa, Kohei Hashimoto, et al.
Japanese Journal of Clinical Oncology (2024) Vol. 54, Iss. 8, pp. 895-902
Open Access | Times Cited: 1
Dual-Action Protein-siRNA Conjugates for Targeted Disruption of CD47-Signal Regulatory Protein α Axis in Cancer Therapy
Jong Won Lee, Hong Yeol Yoon, Young Ji Ko, et al.
ACS Nano (2024) Vol. 18, Iss. 33, pp. 22298-22315
Closed Access | Times Cited: 1
What is the relevance of FoxP3 in the tumor microenvironment and cancer outcomes?
Abdo Meyiah, Eyad Elkord
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 8, pp. 803-809
Closed Access | Times Cited: 1
Triple-negative breast cancer and radiation therapy
Jordana de Faria Bessa, Gustavo Nader Marta
Reports of Practical Oncology & Radiotherapy (2022)
Open Access | Times Cited: 6
Expression and genetic polymorphism of Foxp3 gene and its association to breast cancer susceptibility
Tabarak Sabah Jassim, Rusul Waleed Ali, Nawar Rushdi Jaber
Biomedicine (2023) Vol. 43, Iss. 01, pp. 317-322
Open Access | Times Cited: 2
Overexpression of NRP1 is Associated with Poor Prognosis via Accelerating Immunosuppression in Head and Neck Squamous Cell Carcinoma
Xueming Yang, Xu Teng, Xiaomeng Song, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 2819-2829
Open Access | Times Cited: 2
Complexity and diversity of FOXP3 isoforms: Novel insights into the regulation of the immune response in metastatic breast cancer
Rama Rao Malla, Meghapriya Adem, Anindita Chakraborty
International Immunopharmacology (2023) Vol. 118, pp. 110015-110015
Closed Access | Times Cited: 2
Prognostic Values of CD8+, PARP, and EGFR on Overall Survival in Patients with Triple-Negative Breast Cancer
Rizky Ifandriani Putri, Samuel J Haryono, Bayu Brahma, et al.
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 3, pp. 1025-1034
Open Access
Page 1 - Next Page

Scroll to top